Pinpointing antitumor constituents of Weifuchun capsules through UPLC-Q-TOF-MS/MS fingerprinting, spectrum-effect relationship analysis and human gastric adenocarcinoma cell bioassay validation
Journal of Pharmaceutical and Biomedical Analysis · 2027-01 · 283 · 117751
DOI: 10.1016/j.jpba.2026.117751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2027-01. Verfasst von Ying Jin und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, China. Electronic address: 221124070147@zjut.edu.cn. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma, Drugs, Chinese Herbal, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Weifuchun capsule (WFC) is extensively used for the prevention and treatment of gastric precancerous lesions and as an adjuvant therapy following gastric cancer surgery, yet the specific bioactive components responsible for its antitumor effects remain poorly defined. In this study, we aimed to preliminarily screen the antitumor active constituents of WFC by combining ultra‑performance liquid chromatography‑quadrupole time‑of‑flight tandem mass spectrometry identification with spectrum-effect relationship analysis, while also evaluating batch-to-batch consistency via chromatographic fingerprinting. WFC samples were subjected to ethanol-water extraction followed by sequential liquid-liquid partitioning and viability assays on human gastric adenocarcinoma (AGS) cells revealed that the dichloromethane fraction exhibited the highest inhibition rate (95.84%). The chemical composition of this active fraction was analyzed by UPLC-Q-TOF-MS/MS, and fingerprints were established for ten batches of samples. Hierarchical cluster analysis (HCA), principal component analysis (PCA), and orthogonal partial least squares discriminant analysis (OPLS-DA) were applied to identify differential components among the batches. The relationship between antitumor efficacy and chemical constituents of WFC was investigated using Pearson correlation analysis, grey correlation analysis (GRA), and orthogonal partial least squares regression (OPLS). Eleven key compounds closely related to antitumor activity were identified, nine of which were validated by AGS cell assays. Three ent‑kaurane diterpenoids i.e., glaucocalyxin A, glaucocalyxin B, and oridonin exhibited potent anti‑proliferative activity with half‑maximal inhibitory concentration values ranging from 12.92 to 21.46 μM, whereas the positive control 5‑fluorouracil yielded an IC₅₀ of 73.03 μM under identical experimental conditions. Isorhamnetin, diosmetin, and eriodictyol exhibited moderate inhibitory effects, while naringin, neohesperidin, and hyperoside showed the weakest inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, China. Electronic address: 221124070147@zjut.edu.cn.
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, China. Electronic address: z18317788073@163.com.
- Hangzhou Huqingyu Hall Pharmaceutical Co., Ltd., Hangzhou, China. Electronic address: fuweidong2018@163.com.
- Hangzhou Huqingyu Hall Pharmaceutical Co., Ltd., Hangzhou, China. Electronic address: 45928655@qq.com.
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, China. Electronic address: taoyi1985812@126.com.
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Key Research and Development Program of China
Zitieren
APA
Jin, Y., Zhao, X., Fu, W., Xu, L., & Tao, Y. (2027). Pinpointing antitumor constituents of Weifuchun capsules through UPLC-Q-TOF-MS/MS fingerprinting, spectrum-effect relationship analysis and human gastric adenocarcinoma cell bioassay validation. Journal of Pharmaceutical and Biomedical Analysis, 283, 117751. https://doi.org/10.1016/j.jpba.2026.117751
Vancouver
Jin Y, Zhao X, Fu W, Xu L, Tao Y. Pinpointing antitumor constituents of Weifuchun capsules through UPLC-Q-TOF-MS/MS fingerprinting, spectrum-effect relationship analysis and human gastric adenocarcinoma cell bioassay validation. Journal of Pharmaceutical and Biomedical Analysis. 2027;283:117751. doi:10.1016/j.jpba.2026.117751
BibTeX
@article{Jin2027,
author = {Jin, Ying and Zhao, Xinxin and Fu, Weidong and Xu, Lingxiang and Tao, Yi},
title = {Pinpointing antitumor constituents of Weifuchun capsules through UPLC-Q-TOF-MS/MS fingerprinting, spectrum-effect relationship analysis and human gastric adenocarcinoma cell bioassay validation},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2027},
volume = {283},
pages = {117751},
doi = {10.1016/j.jpba.2026.117751}
}
EUVIMED